BeiGene's proposed HKEX listing could rake in over $900M

BeiGene Ltd. (NASDAQ:BGNE) proposed to raise up to HK$7.3 billion ($932.7 million) in a follow-on on the Hong Kong stock exchange through the sale of 65.6 million shares at HK$94.40-HK$111.60. At the HK$103 midpoint, BeiGene would raise HK$6.8 billion ($861 million).

BeiGene has allotted 5.9 million shares for local Hong Kong investors, with the remainder earmarked for global investors. Underwriters include Morgan Stanley, Goldman Sachs (Asia), Credit Suisse (Hong Kong), CLSA, CICC, Deutsche Bank, UBS and China Renaissance...